$40.2B
$77,000
0.03% of portfolio
300
Q3 2020
New
$17.4B
$87,000
0.03% of portfolio
1,300
Q2 2023
Reduced 54.39%
$62.8B
$93,000
0.03% of portfolio
3,200
Q4 2017
New
$174B
$87,000
0.03% of portfolio
860
Q4 2023
Added 13.16%
$14.1B
$92,000
0.03% of portfolio
9,060
Q1 2023
Reduced 9.94%
$46.4B
$75,000
0.03% of portfolio
840
Q2 2024
Added 2,000.0%
$9.67B
$94,000
0.03% of portfolio
470
Q3 2023
Added 6.82%
$34.4B
$81,000
0.03% of portfolio
2,075
Q4 2023
Reduced 33.17%
$19.6B
$72,000
0.03% of portfolio
2,150
Q2 2024
Reduced 12.24%
$262B
$88,000
0.03% of portfolio
158
Q2 2024
New
$40.6B
$75,000
0.03% of portfolio
575
Q4 2023
New
$70.3B
$74,000
0.03% of portfolio
70
Q2 2024
Reduced 22.22%
$20.4B
$46,000
0.02% of portfolio
625
Q1 2024
Reduced 10.71%
$89.6B
$66,000
0.02% of portfolio
480
Q4 2023
New
$7.01B
$63,000
0.02% of portfolio
1,750
Q4 2021
Reduced 36.36%
$26.3B
$58,000
0.02% of portfolio
609
Q1 2024
Reduced 24.16%
$13.5B
$65,000
0.02% of portfolio
210
Q4 2023
New
$24.8B
$54,000
0.02% of portfolio
500
Q1 2022
Reduced 16.67%
$57.2B
$62,000
0.02% of portfolio
1,280
Q2 2017
New
$166B
$65,000
0.02% of portfolio
145
Q3 2021
New
-
$55,000
0.02% of portfolio
-
Q3 2022
New
$35B
$49,000
0.02% of portfolio
1,400
Q3 2023
Reduced 15.15%
$11.8B
$47,000
0.02% of portfolio
400
Q3 2021
New
Cartesian Therapeutices Inc
-
$48,000
0.02% of portfolio
-
Q2 2024
New
$17.5B
$70,000
0.02% of portfolio
9,382
Q2 2024
Reduced 12.33%
$167B
$63,000
0.02% of portfolio
80
Q3 2020
New
$175B
$48,000
0.02% of portfolio
1,217
Q1 2024
Reduced 19.4%
$114B
$57,000
0.02% of portfolio
900
Q1 2024
Added 57.89%
$58.7B
$71,000
0.02% of portfolio
24
Q4 2023
Reduced 45.45%
$14.6B
$50,000
0.02% of portfolio
1,253
Q1 2024
Reduced 28.52%
$36.6B
$36,000
0.01% of portfolio
400
Q4 2023
Reduced 42.03%
$60.2B
$27,000
0.01% of portfolio
600
Q4 2019
Reduced 45.45%
$35.7B
$34,000
0.01% of portfolio
644
Q3 2020
Reduced 51.98%
$32.7B
$21,000
0.01% of portfolio
350
Q2 2024
Reduced 30.0%
$13B
$27,000
0.01% of portfolio
200
Q4 2019
New
$39.9B
$43,000
0.01% of portfolio
270
Q1 2023
Reduced 33.33%
$104B
$25,000
0.01% of portfolio
610
Q1 2024
Reduced 59.6%
$22B
$24,000
0.01% of portfolio
224
Q1 2022
Reduced 86.82%
$1.01B
$22,000
0.01% of portfolio
600
Q3 2023
New
$41.4B
$39,000
0.01% of portfolio
140
Q4 2021
Reduced 24.32%
$173B
$41,000
0.01% of portfolio
1,000
Q1 2024
Reduced 22.48%
$13.7B
$29,000
0.01% of portfolio
2,712
Q1 2024
Reduced 1.77%
$115B
$37,000
0.01% of portfolio
100
Q1 2018
New
$0
$36,000
0.01% of portfolio
500
Q2 2017
New
$160B
$18,000
0.01% of portfolio
179
Q2 2024
Reduced 17.51%
$15.6B
$41,000
0.01% of portfolio
300
Q2 2017
New
$10.8B
$37,000
0.01% of portfolio
315
Q1 2023
Reduced 29.21%
$18.2B
$21,000
0.01% of portfolio
800
Q3 2023
New
$59.1B
$29,000
0.01% of portfolio
420
Q1 2022
Reduced 21.5%
$0
$39,000
0.01% of portfolio
365
Q2 2024
Reduced 47.71%